Lenalidomide-induced Pseudogout and Crowned Dens Syndrome
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Key Words: lenalidomide, pseudogout, crowned dens syndrome, myelomaAn 84-year-old male diagnosed with IgA myeloma was treated with lenalidomide.The disease was managed adequately; however, after 11 months, he experienced high-grade fever, swelling and pain in his right elbow, and severe posterior neck pain.A cloudy joint fluid was identified (Figure 1A), and the patient was diagnosed with pseudogout.Moreover, he was diagnosed with crowned dens syndrome based on cervical spine findings of computed tomography (Figure 1B).Discontinuation of lenalidomide and administration of nonsteroidal antiinflammatory drugs reduced these symptoms.Nine months after the lenalidomide cessation, myeloma worsened, and readministration of lenalidomide led to generalized arthralgia and severe swelling of the left ankle joint; lenalidomide-induced arthritis occurrence was clinically confirmed.In Japan, 24, 8, and 1 cases of mild arthralgia, arthritis, and joint swelling, respectively, have been reported.Notably, some joint symptoms can be associated with lenalidomide-associated pseudogout.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Lenalidomide-induced Pseudogout and Crowned Dens Syndrome
- Date Crossref
- 01/01/2024
- Éditeur
- Japan Medical Association
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.